Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01742351
Other study ID # 39:2012
Secondary ID
Status Completed
Phase N/A
First received November 16, 2012
Last updated May 2, 2013
Start date January 2013
Est. completion date May 2013

Study information

Verified date May 2013
Source Örebro County Council
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review BoardSweden: The National Board of Health and Welfare
Study type Interventional

Clinical Trial Summary

The aim of the study is to test the feasibility and acceptability of internet-based Cognitive Behaviour Therapy (CBT) for persons diagnosed with bipolar disorder, type II. The idea is to treat residual depressive symptoms as well as using psychoeducation to improve their prognosis. Each participant will have a personal therapist that will provide guidance and support throughout the treatment.


Recruitment information / eligibility

Status Completed
Enrollment 7
Est. completion date May 2013
Est. primary completion date May 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- A diagnosis of bipolar disorder type II

- Mild to moderate depressive symptoms

- 18 years of age

- Stable medication with a mood stabiliser

- Access to the internet

Exclusion Criteria:

- Diagnosis of psychosis

- Having received psychiatric in-patient care during the past year

- Ongoing psychotherapy

- Previous manic episode

- Previous suicide attempt

- Previous parasuicidal behavior documented in patient record (e.g. self-injury)

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Guided internet-based cognitive behavior therapy


Locations

Country Name City State
Sweden Psychiatric Research Centre Örebro

Sponsors (2)

Lead Sponsor Collaborator
Örebro County Council School of Law, Psychology and Social Work, Örebro University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in score on the Montgomery-Åsberg Depression Rating Scale - Self rated (MADRS-S) between baseline and post treatment A nine item questionnaire of depressive symptoms 9 weeks
Secondary Change in the score on the Affective Self Rating Scale (AS-18-M) between baseline and post treatment A nine item subscale of the AS-18 measuring symptoms of mania/hypomania. 9 weeks